Fiduciary Trust International of Pennsylvania’s Vertex Pharmaceuticals VRTX Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$6.96M	Buy	29,260 +14,424	+97%	+$3.31M	0.33%	83
2019 Q4	$3.25M	Buy	14,836 +9,497	+178%	+$1.92M	0.12%	134
2019 Q3	$905K	Sell	5,339 -502	-9%	-$88.8K	0.04%	241
2019 Q2	$1.07M	Buy	5,841 +1,657	+40%	+$290K	0.04%	232
2019 Q1	$770K	Buy	4,184 +2,359	+129%	+$436K	0.03%	227
2018 Q4	$302K	Sell	1,825 -325	-15%	-$56.3K	0.02%	272
2018 Q3	$414K	Sell	2,150 -311	-13%	-$55.4K	0.02%	287
2018 Q2	$418K	Sell	2,461 -28,971	-92%	-$4.49M	0.02%	278
2018 Q1	$5.12M	Buy	31,432 +28,832	+1,109%	+$4.71M	0.24%	122
2017 Q4	$390K	Buy	2,600 +1,155	+80%	+$171K	0.02%	311
2017 Q3	$220K	Buy	+1,445	New	+$217K	0.01%	322

Other funds holding VRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's VRTX Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania increased its Vertex Pharmaceuticals (VRTX) stake by 97% in Q1 2020, buying an estimated $3.31M and bringing the position to 29,260 shares worth $6.96M. The position accounts for 0.33% of the portfolio, ranked #83.

Fiduciary Trust International of Pennsylvania first reported a position in VRTX in Q3 2017 and has held it in 11 quarters since. 856 funds tracked by Wall St. Rank hold VRTX as of Q1 2020.

Fiduciary Trust International of Pennsylvania held 29,260 shares of Vertex Pharmaceuticals worth $6.96M as of Q1 2020.
Fiduciary Trust International of Pennsylvania bought 14,424 Vertex Pharmaceuticals shares in Q1 2020, an estimated $3.31M.
Vertex Pharmaceuticals made up 0.33% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #83 holding.
Fiduciary Trust International of Pennsylvania first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 11 quarters since.
856 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.